AAP
SLS icon

Arax Advisory Partners’s SELLAS Life Sciences SLS Stock Holding History

Arax Advisory Partners’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Buy
+9,173
New +$63.3K ﹤0.01% 2516
2025
Q4 		– Sell
-540
Closed -$869 – 4490
2025
Q3 		$869 Buy
+540
New +$962 ﹤0.01% 3284

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Arax Advisory Partners's SLS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in SELLAS Life Sciences (SLS) in Q2 2026: 9,173 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #2516 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SLS as recently as Q3 2025.

Arax Advisory Partners first reported a position in SLS in Q3 2025 and has held it in 2 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Arax Advisory Partners held 9,173 shares of SELLAS Life Sciences worth $135K as of Q2 2026.
  • SELLAS Life Sciences was a new Arax Advisory Partners position in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2516 holding.
  • Arax Advisory Partners first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.